New England Securities’s iShares Biotechnology ETF IBB Stock Holding History

New England Securities’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.04M	Buy	10,329 +1,365	+15%	+$133K	0.37%	57
2014 Q3	$817K	Buy	8,964 +840	+10%	+$73.7K	0.29%	86
2014 Q2	$696K	Sell	8,124 -24,399	-75%	-$1.92M	0.24%	107
2014 Q1	$2.56M	Sell	32,523 -3,264	-9%	-$272K	0.98%	12
2013 Q4	$2.71M	Buy	35,787 +15,117	+73%	+$1.07M	1.12%	11
2013 Q3	$1.44M	Buy	20,670 +16,626	+411%	+$1.09M	0.73%	26
2013 Q2	$234K	Buy	+4,044	New	+$234K	0.16%	150

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

New England Securities's IBB Position: Q4 2014 in Review

New England Securities increased its iShares Biotechnology ETF (IBB) stake by 15% in Q4 2014, buying an estimated $133K and bringing the position to 10,329 shares worth $1.04M. The position accounts for 0.37% of the portfolio, ranked #57.

New England Securities first reported a position in IBB in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2013. 369 funds tracked by Wall St. Rank hold IBB as of Q4 2014.

New England Securities held 10,329 shares of iShares Biotechnology ETF worth $1.04M as of Q4 2014.
New England Securities bought 1,365 iShares Biotechnology ETF shares in Q4 2014, an estimated $133K.
iShares Biotechnology ETF made up 0.37% of New England Securities's portfolio in Q4 2014, its #57 holding.
New England Securities first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 7 quarters since.
New England Securities's iShares Biotechnology ETF position peaked at $2.71M in Q4 2013.
369 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.